These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34118643)

  • 1. Differential expression of gut miRNAs in idiopathic Parkinson's disease.
    Kurz A; Kumar R; Northoff BH; Wenk C; Schirra J; Donakonda S; Höglinger GU; Schwarz J; Rozanski V; Hübner R; Bötzel K; Holdt LM; Koeglsperger T
    Parkinsonism Relat Disord; 2021 Jul; 88():46-50. PubMed ID: 34118643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of a Parkinson's Disease-Specific MicroRNA Signature in Nasal and Oral Swabs.
    Schließer P; Struebing FL; Northoff BH; Kurz A; Rémi J; Holdt L; Höglinger GU; Herms J; Koeglsperger T
    Mov Disord; 2023 Sep; 38(9):1706-1715. PubMed ID: 37382573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
    He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
    Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms.
    Lebouvier T; Neunlist M; Bruley des Varannes S; Coron E; Drouard A; N'Guyen JM; Chaumette T; Tasselli M; Paillusson S; Flamand M; Galmiche JP; Damier P; Derkinderen P
    PLoS One; 2010 Sep; 5(9):e12728. PubMed ID: 20856865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.
    Yadav SK; Jauhari A; Singh N; Pandey A; Sarkar S; Pandey S; Garg RK; Parmar D; Yadav S
    Cell Mol Neurobiol; 2023 Oct; 43(7):3527-3553. PubMed ID: 37219663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
    Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
    PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
    Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
    Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson's disease patients.
    Shu Y; Qian J; Wang C
    Open Life Sci; 2020; 15(1):647-653. PubMed ID: 33817253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients.
    Tolosa E; Botta-Orfila T; Morató X; Calatayud C; Ferrer-Lorente R; Martí MJ; Fernández M; Gaig C; Raya Á; Consiglio A; Ezquerra M; Fernández-Santiago R
    Neurobiol Aging; 2018 Sep; 69():283-291. PubMed ID: 29935433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
    Vallelunga A; Iannitti T; Dati G; Capece S; Maugeri M; Tocci E; Picillo M; Volpe G; Cozzolino A; Squillante M; Cicarelli G; Barone P; Pellecchia MT
    Mol Biol Rep; 2019 Apr; 46(2):1661-1666. PubMed ID: 30810945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients.
    Ravanidis S; Bougea A; Papagiannakis N; Koros C; Simitsi AM; Pachi I; Breza M; Stefanis L; Doxakis E
    Ann Clin Transl Neurol; 2020 Sep; 7(9):1594-1607. PubMed ID: 32860338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating exosomal miRNAs as diagnostic biomarkers in Parkinson's disease.
    Yao YF; Qu MW; Li GC; Zhang FB; Rui HC
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5278-5283. PubMed ID: 30178852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of SNCA variants with α-synuclein of gastric and colonic mucosa in Parkinson's disease.
    Chung SJ; König IR; Lohmann K; Hinrichs F; Kim J; Ryu HS; Lee HJ; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Hong SM; Myung SJ; Klein C
    Parkinsonism Relat Disord; 2019 Apr; 61():151-155. PubMed ID: 30424941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analyses identify differentially expressed micrornas in Parkinson's disease.
    Schulz J; Takousis P; Wohlers I; Itua IOG; Dobricic V; Rücker G; Binder H; Middleton L; Ioannidis JPA; Perneczky R; Bertram L; Lill CM
    Ann Neurol; 2019 Jun; 85(6):835-851. PubMed ID: 30990912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in microRNA expression in levodopa-naive PD patients.
    Vallelunga A; Iannitti T; Somma G; Russillo MC; Picillo M; De Micco R; Vacca L; Cilia R; Cicero CE; Zangaglia R; Lazzeri G; Galantucci S; Radicati FG; De Rosa A; Amboni M; Scaglione C; Tessitore A; Stocchi F; Eleopra R; Nicoletti A; Pacchetti C; Di Fonzo A; Volontè MA; Barone P; Pellecchia MT
    J Neurol; 2023 Jul; 270(7):3574-3582. PubMed ID: 37052669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum microRNA expression levels in Turkish patients with Parkinson's disease.
    Ozdilek B; Demircan B
    Int J Neurosci; 2021 Dec; 131(12):1181-1189. PubMed ID: 32546033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-4639 Is a Regulator of DJ-1 Expression and a Potential Early Diagnostic Marker for Parkinson's Disease.
    Chen Y; Gao C; Sun Q; Pan H; Huang P; Ding J; Chen S
    Front Aging Neurosci; 2017; 9():232. PubMed ID: 28785216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.
    Barrenschee M; Zorenkov D; Böttner M; Lange C; Cossais F; Scharf AB; Deuschl G; Schneider SA; Ellrichmann M; Fritscher-Ravens A; Wedel T
    Acta Neuropathol Commun; 2017 Jan; 5(1):1. PubMed ID: 28057070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.